Cargando…
Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial
BACKGROUND: Sarcopenia (the age-related loss of muscle mass and function) is a major contributor to loss of mobility, falls, loss of independence, morbidity and mortality in older people. Although resistance training is effective in preventing and reversing sarcopenia, many older people are sedentar...
Autores principales: | Band, Margaret M., Sumukadas, Deepa, Struthers, Allan D., Avenell, Alison, Donnan, Peter T., Kemp, Paul R., Smith, Karen T., Hume, Cheryl L., Hapca, Adrian, Witham, Miles D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753568/ https://www.ncbi.nlm.nih.gov/pubmed/29301558 http://dx.doi.org/10.1186/s13063-017-2390-9 |
Ejemplares similares
-
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial
por: Achison, Marcus, et al.
Publicado: (2022) -
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial
por: Rossios, Christos, et al.
Publicado: (2023) -
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia—Analyses from the LACE randomised controlled trial
por: Bashir, Tufail, et al.
Publicado: (2023) -
Do ACE Inhibitors Improve the Response to Exercise Training in Functionally Impaired Older Adults? A Randomized Controlled Trial
por: Sumukadas, Deepa, et al.
Publicado: (2014) -
Treating sarcopenia: the LACE trial
por: Clark, Andrew L., et al.
Publicado: (2022)